Ping Identity provides cloud-based identity management software for companies and government organizations. Ping Identity was acquired by Vista Equity Partners in 2016.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
Oakley Networks was a leader in insider threat protection, combining network and endpoint monitoring with targeted investigations to protect enterprises. Oakley Networks was acquired by Raytheon in 2007.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
GeoTel is a producer of call-routing telecommunications software. GeoTel was acquired by Cisco in 1999.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
Airespace was a market leader in the design and development of wireless networking platforms that support business-critical applications. The company’s AireWave Director(TM) Software provided dynamic RF intelligence for network optimization, air tight security, seamless mobility, and support for real-time applications, such as voice. With Airespace, enterprises could maximize the value of mobility by putting the air space to work. Airespace was acquired by Cisco in 2005.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
Xoom is a digital money transfer company that allows users to securely transfer money online. Xoom went public in 2013 and was then acquired by PayPal in 2015.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
Quartet Health is developing care coordination software and services designed to improve clinical outcomes and reduce the cost of care for patients where behavioral health is the primary or a comorbid condition. Quartet Health was acquired by NeuroFlow in 2025.
Semma Therapeutics is a regenerative medicine company founded to develop transformative stem cell-derived therapies to provide a functional cure for patients with diabetes. This company was acquired by Vertex in 2019.
Avidity Biosciences is a biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC™) – which combine the strengths of monoclonal antibodies and siRNA-based therapeutics to overcome barriers to the delivery of siRNA and target genetic drivers of disease. Avidity Biosciences, (formerly NASDAQ: RNA/RNAM) is no longer a publicly traded company. Novartis acquired Avidity.
Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD73, CD39, IL-27 and CD47. Surface Oncology went public in 2018 (NASDAQ: SURF). The company has since been acquired by Coherus BioSciences and is no longer a publicly traded company. Surface Oncology was acquired in 2023.
Adaptimmune (NASDAQ: ADAP) is a cellular therapeutics company developing affinity enhanced T-cell receptor (TCR) engineered T-cells to treat solid tumor and hematological cancers. Adaptimmune was acquired by WorldMeds in 2025.